The biotech, which raised more than $800 million privately on the promise of artificial intelligence-aided drug discovery, is developing a potential competitor to the asthma treatment Tezspire.Dive Brief:Generate Biomedicines, a well-funded startup banking on the promise of artificial intelligence in drug development, filed papers for an initial public offering on Wednesday. Founded by the prolific […]
